GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sikarin PCL (BKK:SKR) » Definitions » EBIT

Sikarin PCL (BKK:SKR) EBIT : ฿1,190 Mil (TTM As of Mar. 2024)


View and export this data going back to 1988. Start your Free Trial

What is Sikarin PCL EBIT?

Sikarin PCL's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was ฿307 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was ฿1,190 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sikarin PCL's annualized ROC % for the quarter that ended in Mar. 2024 was 12.17%. Sikarin PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 19.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sikarin PCL's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.67%.


Sikarin PCL EBIT Historical Data

The historical data trend for Sikarin PCL's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sikarin PCL EBIT Chart

Sikarin PCL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 362.26 474.06 1,834.34 1,328.49 1,161.60

Sikarin PCL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 278.77 296.22 327.55 259.05 307.18

Competitive Comparison of Sikarin PCL's EBIT

For the Medical Care Facilities subindustry, Sikarin PCL's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sikarin PCL's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sikarin PCL's EV-to-EBIT falls into.



Sikarin PCL EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1,190 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sikarin PCL  (BKK:SKR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sikarin PCL's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=1199.172 * ( 1 - 20.22% )/( (7865.117 + 7857.161)/ 2 )
=956.6994216/7861.139
=12.17 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9246.453 - 693.713 - ( 687.623 - max(0, 1140.622 - 2219.808+687.623))
=7865.117

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=9293.052 - 633.701 - ( 802.19 - max(0, 979.609 - 2335.636+802.19))
=7857.161

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Sikarin PCL's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1228.704/( ( (6453.174 + max(-27.991, 0)) + (6427.432 + max(-37.134, 0)) )/ 2 )
=1228.704/( ( 6453.174 + 6427.432 )/ 2 )
=1228.704/6440.303
=19.08 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(463.97 + 152.558 + 58.04) - (693.713 + 0 + 8.8460000000002)
=-27.991

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(406.539 + 156.682 + 41.076) - (633.701 + 0 + 7.73)
=-37.134

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sikarin PCL's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=1189.998/21005.155
=5.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sikarin PCL EBIT Related Terms

Thank you for viewing the detailed overview of Sikarin PCL's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Sikarin PCL (BKK:SKR) Business Description

Traded in Other Exchanges
N/A
Address
976, Lasalle Road, Bangna Tai, Bangna, Bangkok, THA, 10260
Sikarin PCL is a Thailand-based company operating in the healthcare sector. It operates private hospitals located in eastern Bangkok, Samutprakarn province and Hat Yai District, Songkhla Province namely Sikarin Hospital, Sikarin Samut Prakan Hospital and Sikarin Hat Yai Hospital. Its services include general surgery services, obstetrics, aesthetic center, dental center, orthopedic center, checkup center, emergency and trauma center, and children center, among others.

Sikarin PCL (BKK:SKR) Headlines

No Headlines